期刊文献+

p53和p21^(WAF1)在鼻咽癌rAd-p53瘤内注射前后的表达及其与近期预后的关系 被引量:3

Expression of p53 and p21^(WAF1) Protein in Advanced Nasopharyngeal Carcinoma before and after Intratumoral Injection of RAd-p53 and Their Relationships with Short-term Prognosis
下载PDF
导出
摘要 目的探讨重组人p53腺病毒(rAd-p53)瘤内注射前后鼻咽癌(NPC)组织中p53蛋白和p21WAF1蛋白的表达情况,及其与鼻咽癌近期疗效的关系。方法应用免疫组织化学法检测12例鼻咽慢性炎组织和63例确诊中晚期鼻咽癌组织的p53和p21WAF1蛋白表达情况。63例中晚期鼻咽癌随机分为2组:p53治疗组(32例):rAd-p53瘤内注射+同步放化疗;常规治疗组(31例):同步放化疗。分析两组治疗前及放疗至20 Gy时p53和p21WAF1蛋白表达情况及其与预后的关系。结果 NPC组织中p53和p21WAF1蛋白阳性表达率分别为49.21%和46.03%,和鼻咽黏膜慢性炎相比差异有统计学意义(P<0.05)。NPC组织中p53和p21WAF1蛋白表达有相关性(rs=0.556,P=0.000)。放疗前及放疗至20 Gy时,鼻咽癌p53治疗组和p21WAF1蛋白阳性表达率差异有统计学意义(P<0.05);两组p53蛋白和p21WAF1蛋白阳性表达与1年无瘤生存率有关(P<0.05)。结论 rAd-p53瘤内注射后p53和p21WAF1蛋白的阳性表达可能在抑制鼻咽癌复发或转移进程中起着重要作用,并预示较好的预后。 Objective To investigate the expression of p53 and p21WAF1 in the NPC cells before and after intratumoral injection of recombinant adenovirus p53(rAd-p53) and their relationships with short-term prognosis.Methods The expression of p53 and p21WAF1 protein were examined by immunochemistry in 12 cases of chronic nasopharynxitis and 63 cases with advanced stage nasopharyngeal carcinoma.Sixty-three cases of NPC were randomly divided into two groups:the p53 therapy group(32 cases) for rAd-p53 intratumoral injection plus radiotherapy and chemotherapy;and the common therapy group(31 cases) for radiotherapy and chemotherapy.The expression levels of p53 and p21WAF1 in biopsy samples from all the cases before and at the 20 Gy of radiotherapy were analyzed;And their relationship with prognosis was also analyzed.Results The expression of p53 and p21WAF1 in 63 cases of NPC was 49.21% and 46.03%,respectively.There was a significant difference between NPC and chronic pharyngitis tissues(P〈0.05).There was correlation between p53 and p21WAF1 expression in NPC tissues(rs=0.556,P=0.000).Before radiotherapy and at the 20 Gy of radiotherapy,positive expression of p21WAF1 in the p53 therapy group was significant difference(P〈0.05);and the positive expression of p53 and p21WAF1 was related to the 1-year disease-free survival rate in both groups(P〈0.05).Conclusion The positive expressions of p53 and p21WAF1 after rAd-p53 intratumoral injection may play an important role in repressing the recurrence and metastasis of NPC,which indicates a better prognosis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第8期961-965,共5页 Cancer Research on Prevention and Treatment
基金 广西医疗卫生重点科研课题资助项目(重200721) 广西壮族自治区卫生厅自筹经费科研课题资助项目(Z2008047)
关键词 鼻咽癌 RAD-P53 p53蛋白 P21WAF1蛋白 预后 Nasopharyngeal carcinoma rAd-p53 p53 p21WAF1 Prognosis
  • 相关文献

参考文献14

  • 1Hoe SL,Lee ES,Khoo AS,et al. p53 and nasopharyngeal carci?norna- a Malaysian study[J]. Pathology,200'J,41 (6) :561-5.
  • 2司勇锋,何承诚,兰桂萍,黄波,张政,陆锦龙,周日晶,江河.重组人p53腺病毒注射液联合放 化疗对中晚期鼻咽癌消退率的影响[J].中国肿瘤临床,2009,36(18):1031-1033. 被引量:12
  • 3Pan JJ, Zhang SW, Chen CB, et al. Effect of recombinant ade?novirus-p53 combined with radiotherapy on long-term progno?sis of advanced nasopharyngeal carcinoma [J]. J Clin Oncol , 2(0)),27 (5) : 799-804.
  • 4Yang H, Zhao R, Lee MH. 14-3- 3sigma, a p53 regulator, sup?presses tumor growth of nasopharyngeal carcinoma [J]. Mol Cancer Ther , 2006,5 (2) : 253-60.
  • 5Stefancikova L. Moulis M, Fabian P, et al. Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle celllymphoma[J]. Int J Oncol,2010,36(3) :699-706.
  • 6Baker L. Quinlan PR, Patten N, et al. p53 mutation, deprivation and poor prognosis in primary breast cancer[J]. Br J Cancer, 2010,1 02( 4) : 719-26.
  • 7Prives C, Hall PA. The p53 pathway[J]. J Pathol, 1999, 187 (1): 112-26.
  • 8Ogino S, Nosho K, Shima K, et al. p21 expression in colon cancer and modifying effects of patient age and body mass in?dex on prognosis[J]. Cancer Epidemiol Biomarkers Prev , 2009, 18(9): 2513-21.
  • 9Hafkamp HC,Mooren JJ,Claessen SM,et al. P21 Cip1/WAF 1 ex?pression is strongly associated with HPV-positive tonsillar carcino?ma and a favorable prognosis[J], Mod Pathol,2009,22(5) :6R6-98.
  • 10徐刚,王槐富,何刚,陈德忠.鼻腔NK/T细胞淋巴瘤中p53和p21表达及其与细胞增殖和凋亡的关系[J].临床耳鼻咽喉头颈外科杂志,2009,23(2):73-76. 被引量:7

二级参考文献31

共引文献39

同被引文献24

  • 1郭文.鼻咽癌治疗药 重组人p53腺病毒(rhAd-p53)[J].世界临床药物,2006,27(7):443-443. 被引量:3
  • 2Peng Z. Current status of gendicine in China:recombinant human Ad-p53 agent for treatment of cancers [ J ]. Hum Gene Ther,2005,16(9) :1 016-1 027.
  • 3Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metal- loproteinases:biologic activity and clinical implications[ J]. Glin Oncol,2000,180(5) :1 135 - 1 149.
  • 4Yoon SO, Park SJ, Yun CH, et al. Roles of matrix metaUo- proteinases in tumor metastasis and angiogenesis[ J]. J Bio- chem Mol Biol,2003,36( 1 ) : 128 - 137.
  • 5John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis[ J ]. Pathol On- col Res,2001,7 ( 1 ) : 14 - 23.
  • 6Freije JM, Dtez-Itza I, Balbfn M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metallo- proteinase produced by breast carcinomas[ J]. J Biol Chem, 1994,269(24) :16 766 -16 733.
  • 7Coussens LM,Werb Z. Matrix metalloproteinases and the devel- opment of cancer[ ]]. Chem Bio1,1996,3(11) :895 -904.
  • 8Kawamata H, Uchida D, Hamano H, et al. Active-MMP2 in cancer cell nests of oral cancer patients:correlation with lymph node metastasis[J], lnt J Onco1,1998,13(4) :699 -704.
  • 9Huang MY,Chang HJ,Chung FY,et al. MMP13 is a poten- tial prognostic marker for colorectal cancer[ J]. Oncol Rep, 2010,24(5) :1 241 -1 247.
  • 10Leeman MF, Curran S,Murray GI. The structure,regulation, and function of human matrix metalloproteinase-13 [ J ]. Crit Rev Bioehem Mol Biol,2002,37 ( 3 ) : 149 - 166.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部